RxDoctor Payments Data

Robert Dangelo, MD

Cardiovascular Disease · Lebanon, NHNPI 1225487630

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (51.6%), travel and lodging and education — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Abbott at 37.7% of the total. Reporting peaked in 2023 at $4,562 and has fallen 63.0% since, to $1,688 in 2025. Among cardiovascular disease clinicians in NH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,787in general payments, 2019–2025

Across 78 payments — averaging $125.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$4K
  • Biotronik Inc.$2K
  • Boston Scientific$2K
  • Medtronic$732
  • Biosense Webster, Inc.$566
  • Medical Device Business Services, Inc.$531

What the payments were for

  • Grants$3003%
  • Travel & lodging$3,78339%
  • Food & beverage$5,04652%
  • Education$6587%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,787 in reported general payments places this provider in the 90th percentile of 112 cardiovascular disease providers in New Hampshire.

See all cardiovascular disease providers in New Hampshire

Medicare billing

Part B allowed, 2024
$56,106
Medicare patients
333
Services billed
435

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Lebanon

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →